Positive expression for CD44, Musashi-1 and CD133 was observed in 77% (82 out of 106), 85% (87 out of 102) and 44% (45 out of 103) of primary GC samples from TMA1 (Table 1), respectively. This evidence concerns the gene CD44 and gastric cancer.